Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000088

President and CEO gave up 21,609 shares (to pay taxes)

  • President and CEO acquired 83,277 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Stewart Robert A · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-07 Exercise or conversion : show line 1 in the form +83,277 100,277 D
2019-05-07 Shares withheld for taxes : show line 2 in the form −21,609 $13.44 $290,425 78,668 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-05-07 Exercise or conversion : show line 3 in the form Restricted Stock Units −83,277 249,834 D
Loading xslF345X03/wf-form4_155743819080725.xml…